Spandow Oliver J.
SEC CIK 1749836 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NEPH | NEPHROS INC | Dir | 122.9K | — | — | 5 | 2021-12-14 | 2025-11-10 |
Most active insiders at NEPH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Nettis Lisa Marie | Dir | — | — |
| 2 | Banks Robert R. Jr. | Pres, CEO | — | — |
| 3 | Spandow Oliver J. | Dir | — | — |
| 4 | Krandel Judy | CFO | — | — |
| 5 | Amron Arthur H | Dir | — | — |
| 6 | WEXFORD CAPITAL LP | 10% | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-13 | 2025-11-10 | NEPH | NEPHROS INC | Spandow Oliver J. | Dir | A - Grant | $0.00 | +8,036 | 122.9K | +7% | $0 | |
| D | 2025-01-03 | 2025-01-01 | NEPH | NEPHROS INC | Spandow Oliver J. | Dir | A - Grant | $0.00 | +33.2K | 114.8K | +41% | $0 |
| 2023-12-15 | 2023-12-13 | NEPH | NEPHROS INC | Spandow Oliver J. | Dir | A - Grant | $0.00 | +14.3K | 81.6K | +21% | $0 | |
| D | 2023-01-09 | 2023-01-05 | NEPH | NEPHROS INC | Spandow Oliver J. | Dir | A - Grant | $0.00 | +42.5K | 67.3K | +171% | $0 |
| D | 2021-12-16 | 2021-12-14 | NEPH | NEPHROS INC | Spandow Oliver J. | Dir | A - Grant | $0.00 | +5,429 | 24.8K | +28% | $0 |
Purchase Sale Sale after option exercise All abbreviations